Work

NOHA: A sensitive, low-cost, and accessible blood-based biomarker to determine breast cancer estrogen receptor status in low-resource settings.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.580

Authors: Srinidi Mohan, Augustine Musyoka, Divya Guthikonda, Jamie Saunders, Lora Girata, Alex Mremi, Furaha Serventi, Blandina Mbaga, Elizabeth Patrick, Michael A Jones, Ivette F. Emery, Frances L. Lucas, Susan Miesfeldt

Institutions: University of New England, Kilimanjaro Christian Medical Centre, Maine Medical Center Research Institute, Maine Medical Center, Maine Medical Center, Spectrum Health

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4281700139

Cites:

Cited by: 1

Related to: 10